Ligand Pharmaceuticals LGND
Last Price
52 Week Range
$93.58 - $212.49
Next Earnings Date
Feb 26 2026 (Estimate)
Next Earnings Date
Feb 26 2026 (Est.)
Last Price
LGND Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Ligand Pharmaceuticals Incorporated | 8-K | December 18, 2025 | |
Ligand Pharmaceuticals Incorporated | 10-Q | November 7, 2025 | |
Ligand Pharmaceuticals Incorporated | 8-K | November 6, 2025 | |
Ligand Pharmaceuticals Incorporated | 8-K | September 16, 2025 | |
Ligand Pharmaceuticals Incorporated | 8-K | August 14, 2025 | |
Ligand Pharmaceuticals Incorporated | 8-K | August 11, 2025 | |
Ligand Pharmaceuticals Incorporated | 10-Q | August 8, 2025 | |
Ligand Pharmaceuticals Incorporated | 8-K | August 7, 2025 | |
Ligand Pharmaceuticals Incorporated | 8-K | July 2, 2025 | |
Ligand Pharmaceuticals Incorporated | 8-K | June 9, 2025 | |
Ligand Pharmaceuticals Incorporated | 10-Q | May 9, 2025 | |
Ligand Pharmaceuticals Incorporated | 8-K | May 8, 2025 | |
Ligand Pharmaceuticals Incorporated | DEF 14A | April 22, 2025 | |
Ligand Pharmaceuticals Incorporated | DEFA14A | April 22, 2025 | |
Ligand Pharmaceuticals Incorporated | ARS | April 22, 2025 | |
Ligand Pharmaceuticals Incorporated | 8-K | April 17, 2025 | |
Ligand Pharmaceuticals Incorporated | 10-K | February 28, 2025 | |
Ligand Pharmaceuticals Incorporated | 8-K | February 27, 2025 | |
Ligand Pharmaceuticals Incorporated | 8-K | February 25, 2025 | |
Ligand Pharmaceuticals Incorporated | 10-Q | November 8, 2024 | |
Ligand Pharmaceuticals Incorporated | 8-K | November 7, 2024 | |
Ligand Pharmaceuticals Incorporated | 10-Q | August 7, 2024 | |
Ligand Pharmaceuticals Incorporated | 8-K | August 6, 2024 | |
Ligand Pharmaceuticals Incorporated | 8-K | August 2, 2024 | |
Ligand Pharmaceuticals Incorporated | 8-K | July 17, 2024 | |
Ligand Pharmaceuticals Incorporated | 8-K | July 10, 2024 | |
Ligand Pharmaceuticals Incorporated | 8-K | July 8, 2024 | |
Ligand Pharmaceuticals Incorporated | 8-K | June 27, 2024 | |
Ligand Pharmaceuticals Incorporated | 8-K | June 18, 2024 | |
Ligand Pharmaceuticals Incorporated | 8-K | June 17, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.